Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 242

Similar articles for PubMed (Select 9495218)

1.

HIV-1 reverse transcriptase codon 215 mutation in plasma RNA: immunologic and virologic responses to zidovudine. The AIDS Clinical Trials Group Study 175 Virology Team.

Rey D, Hughes M, Pi JT, Winters M, Merigan TC, Katzenstein DA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Mar 1;17(3):203-8.

PMID:
9495218
2.
3.

Occurrence of HIV-1 reverse transcriptase gene mutation at codon 215 in HIV-infected infants.

Kamkamidze G, Sullivan T, Charbonneau T.

J Clin Virol. 2001 Aug;22(1):143-8.

PMID:
11418362
5.

Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine.

Izopet J, Bicart-See A, Pasquier C, Sandres K, Bonnet E, Marchou B, Puel J, Massip P.

J Med Virol. 1999 Dec;59(4):507-11.

PMID:
10534734
6.

Genotypic correlates of a virologic response to stavudine after zidovudine monotherapy.

Shulman NS, Machekano RA, Shafer RW, Winters MA, Zolopa AR, Liou SH, Hughes M, Katzenstein DA; AIDS Clinical Trials Group 302 Study Team.

J Acquir Immune Defic Syndr. 2001 Aug 1;27(4):377-80.

PMID:
11468426
7.
8.
9.

Genotypic resistance to zidovudine as a predictor of failure of subsequent therapy with human immunodeficiency virus type-1 nucleoside reverse-transcriptase inhibitors.

Venturi G, Romano L, Catucci M, Riccio ML, De Milito A, Gonnelli A, Rubino M, Valensin PE, Zazzi M.

Eur J Clin Microbiol Infect Dis. 1999 Apr;18(4):274-82.

PMID:
10385016
10.

HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patients.

Kozal MJ, Shafer RW, Winters MA, Katzenstein DA, Aguiniga E, Halpern J, Merigan TC.

J Acquir Immune Defic Syndr. 1994 Aug;7(8):832-8.

PMID:
7517448
11.

Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals.

Balotta C, Berlusconi A, Pan A, Violin M, Riva C, Colombo MC, Gori A, Papagno L, Corvasce S, Mazzucchelli R, Facchi G, Velleca R, Saporetti G, Galli M, Rusconi S, Moroni M.

Antivir Ther. 2000 Mar;5(1):7-14.

PMID:
10846586
12.

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.

Gómez-Cano M, Rubio A, Puig T, Pérez-Olmeda M, Ruiz L, Soriano V, Pineda JA, Zamora L, Xaus N, Clotet B, Leal M.

AIDS. 1998 Jun 18;12(9):1015-20.

PMID:
9662197
13.

Phenotypic and genotypic resistance to nucleoside reverse transcriptase inhibitors in HIV-1 clinical isolates.

Lafeuillade A, Poggi C, Hittinger G, Chadapaud S.

HIV Med. 2001 Oct;2(4):231-5.

PMID:
11737402
14.
16.

HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.

Welles SL, Pitt J, Colgrove R, McIntosh K, Chung PH, Colson A, Lockman S, Fowler MG, Hanson C, Landesman S, Moye J, Rich KC, Zorrilla C, Japour AJ.

AIDS. 2000 Feb 18;14(3):263-71.

PMID:
10716502
17.

Thymidine analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolated from zidovudine-naive patients experiencing viremia on stavudine-containing regimens.

Ross L, Scarsella A, Raffanti S, Henry K, Becker S, Fisher R, Liao Q, Hirani A, Graham N, St Clair M, Hernandez J; NZT40012 Study Team.

AIDS Res Hum Retroviruses. 2001 Aug 10;17(12):1107-15.

PMID:
11522180
18.

Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine-experienced patients.

Shulman NS, Hughes MD, Winters MA, Shafer RW, Zolopa AR, Hellmann NS, Bates M, Whitcomb JM, Katzenstein DA.

J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):121-7.

PMID:
12394789
19.

Short-term evolution of HIV-1 viraemia and CD4+ cell counts in patients who have a primary mutation to zidovudine.

Rubio A, Leal M, Rey C, Pineda JA, Sanchez-Quijano A, Lissen E.

AIDS. 1998 Mar 5;12(4):395-8.

PMID:
9520169
20.

Selective vertical transmission of HIV-1 antiretroviral resistance mutations.

Colgrove RC, Pitt J, Chung PH, Welles SL, Japour AJ.

AIDS. 1998 Dec 3;12(17):2281-8.

PMID:
9863870
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk